List of bibliographic references indexed by coronaviruses
Number of relevant bibliographic references: 43.
[0-20] [
0 - 20][
0 - 43][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000180 (2021) |
Ilad Alavi Darazam [Iran] ; Shervin Shokouhi [Iran] ; Mohamad Amin Pourhoseingholi [Iran] ; Seyed Sina Naghibi Irvani [Iran] ; Majid Mokhtari [Iran] ; Minoosh Shabani [Iran] ; Mahdi Amirdosara [Iran] ; Parham Torabinavid [Iran] ; Maryam Golmohammadi [Iran] ; Sayedpayam Hashemi [Iran] ; Arsalan Azimi [Iran] ; Mohammad Hossein Jafarazadeh Maivan [Iran] ; Omidvar Rezaei [Iran] ; Alireza Zali [Iran] ; Mohammadreza Hajiesmaeili [Iran] ; Hadiseh Shabanpour Dehbsneh [Iran] ; Akram Hoseyni Kusha [Iran] ; Maryam Taleb Shoushtari [Iran] ; Negar Khalili [Iran] ; Azam Soleymaninia [Iran] ; Latif Gachkar [Iran] ; Ali Khoshkar [Iran] | Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. |
| 000277 (2021) |
Gustavo José Da Silva Pereira [Brésil] ; Anderson Henrique França Figueredo Leão [Brésil] ; Adolfo Garcia Erustes [Brésil] ; Ingrid Beatriz De Melo Morais [Brésil] ; Talita Aparecida De Moraes Vrechi [Brésil] ; Lucas Dos Santos Zamarioli [Brésil] ; Cássia Arruda Souza Pereira [Brésil] ; Laís De Oliveira Marchioro [Brésil] ; Letícia Paulino Sperandio [Brésil] ; Ísis Valeska Freire Lins [Brésil] ; Mauro Piacentini [Italie] ; Gian Maria Fimia [Italie] ; Patrícia Reckziegel [Brésil] ; Soraya Soubhi Smaili [Brésil] ; Claudia Bincoletto [Brésil] | Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19. |
| 000345 (2021) |
Claudia Musial [Pologne] ; Magdalena Gorska-Ponikowska [Pologne] | Medical progress: Stem cells as a new therapeutic strategy for COVID-19. |
| 000441 (2021) |
Asokan Devarajan [États-Unis] ; Marmar Vaseghi [États-Unis] | Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights. |
| 000510 (2021) |
Smarajit Maiti [Inde] ; Amrita Banerjee [Inde] | Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study. |
| 000548 (2021) |
Andrea Giacomelli [Italie] ; Gabriele Pagani [Italie] ; Anna L. Ridolfo [Italie] ; Letizia Oreni [Italie] ; Federico Conti [Italie] ; Laura Pezzati [Italie] ; Lucia Bradanini [Italie] ; Giacomo Casalini [Italie] ; Cinzia Bassoli [Italie] ; Valentina Morena [Italie] ; Simone Passerini [Italie] ; Giuliano Rizzardini [Italie, Afrique du Sud] ; Chiara Cogliati [Italie] ; Elisa Ceriani [Italie] ; Riccardo Colombo [Italie] ; Stefano Rusconi [Italie] ; Cristina Gervasoni [Italie] ; Dario Cattaneo [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. |
| 000590 (2021) |
Maryam Hosseini [États-Unis] ; Wanqiu Chen [États-Unis] ; Daliao Xiao [États-Unis] ; Charles Wang [États-Unis] | Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs. |
| 000735 (2021) |
Khanit Sa-Ngiamsuntorn [Thaïlande] ; Ampa Suksatu [Thaïlande] ; Yongyut Pewkliang [Thaïlande] ; Piyanoot Thongsri [Thaïlande] ; Phongthon Kanjanasirirat [Thaïlande] ; Suwimon Manopwisedjaroen [Thaïlande] ; Sitthivut Charoensutthivarakul [Thaïlande] ; Patompon Wongtrakoongate [Thaïlande] ; Supaporn Pitiporn [Thaïlande] ; Jarinya Chaopreecha [Thaïlande] ; Supasek Kongsomros [Thaïlande] ; Kedchin Jearawuttanakul [Thaïlande] ; Warawuth Wannalo [Thaïlande] ; Phisit Khemawoot [Thaïlande] ; Somchai Chutipongtanate [Thaïlande] ; Suparerk Borwornpinyo [Thaïlande] ; Arunee Thitithanyanont [Thaïlande] ; Suradej Hongeng [Thaïlande] | Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives. |
| 000745 (2021) |
Yamei Zhang [Irlande (pays)] ; Siobhan Gargan [Irlande (pays)] ; Yongxu Lu [Royaume-Uni] ; Nigel J. Stevenson [Irlande (pays), Bahreïn] | An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity. |
| 000839 (2020) |
Meda Venkatasubbaiah [Inde] ; P. Dwarakanadha Reddy [Inde] ; Suggala V. Satyanarayana [Inde] | Literature-based review of the drugs used for the treatment of COVID-19. |
| 000855 (2020) |
Dinesh Kaul [Inde] | An overview of coronaviruses including the SARS-2 coronavirus - Molecular biology, epidemiology and clinical implications. |
| 000881 (2020) |
M. Roustit [France] ; R. Guilhaumou [France] ; M. Molimard [France] ; M-D Drici [France] ; S. Laporte [France] ; J-L Montastruc [France] | Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence. |
| 000A49 (2020) |
Jelena Stojkovic-Filipovic [Serbie] ; Martina Bosic [Serbie] | Treatment of COVID 19-Repurposing drugs commonly used in dermatology. |
| 000A52 (2020) |
Tung Hoang [Corée du Sud] ; Tho Tran Thi Anh [Viêt Nam] | Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence. |
| 000A91 (2020) |
Rishita Pujari [États-Unis] ; Mary V. Thommana [États-Unis] ; Brisandi Ruiz Mercedes [États-Unis] ; Ayna Serwat [États-Unis] | Therapeutic Options for COVID-19: A Review. |
| 000B20 (2020) |
Frédéric Carrière [France] ; Sonia Longhi [France] ; Michel Record [France] | The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway. |
| 000D58 (2020) |
Tarek Mohamed Abd El-Aziz [Égypte] ; James D. Stockand [États-Unis] | Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. |
| 000F10 (2020) |
Allan Sauvat [France] ; Fabiola Ciccosanti [Italie] ; Francesca Colavita [Italie] ; Martina Di Rienzo [Italie] ; Concetta Castilletti [Italie] ; Maria Rosaria Capobianchi [Italie] ; Oliver Kepp [France] ; Laurence Zitvogel [France, République populaire de Chine] ; Gian Maria Fimia [Italie] ; Mauro Piacentini [Italie] ; Guido Kroemer [France, République populaire de Chine, Suède] | On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. |
| 000F31 (2020) |
Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France] | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| 000F62 (2020) |
Yusuf Muhammed [Nigeria] | Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment. |
| 000F66 (2020) |
Meshari Alazmi [Arabie saoudite] ; Olaa Motwalli | Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "coronaviruses"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i \
-Sk "coronaviruses" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= AbsEn.i
|clé= coronaviruses
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
